Please login to the form below

Not currently logged in

Novo uses voucher for speedy answer on oral semaglutide

Novo Nordisk headquartersOral version of Ozempic could be diabetes market leader

Is Orkambi deal close? Vertex meets again today with NHS England

OrkambiCampaigners hopes rise after three year wait

Amgen, Servier heart failure drug clears trial hurdle

Amgen flagDrug could be a blockbuster - if it hits key endpoints

NHS needs £900m a year to avoid crippling staff shortages

NHS England logoReport predicts nurse shortage will triple to over 100,000 within the next 10 years

Pfizer hedges bets on gene therapy deal

Company not splashing out like Roche's Spark purchase

Sage’s postpartum depression treatment Zulresso gains US approval

First approval of its kind

Urovant slips on phase 3 incontinence drug data

UrovantUnderwhelming results send shares down

Roche, AbbVie hit by clinical hold for Venclexta in myeloma

VenclextaSafety concerns could hit blockbuster expectations

The Communiqué Awards: what are judges looking for?

Judges in the Communiqué Awards reveal how to bring creativity and strategic thinking together

Latest appointments

Featured jobs

Subscribe to our email news alerts


Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

Where next in Alzheimer’s disease R&D?
How past failures and emerging biology are reshaping drug development...
Brain scan
Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...